MedTrace Logo

Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models

NCT02709174 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-10-04

No results posted yet for this study

Summary

Objective: To evaluate whether trimester specific d-dimer levels and brain natriuretic protein (BNP), along with the modified Wells score (MWS), is a useful risk stratification tool to exclude pregnant women at low-risk of pulmonary embolism (PE) from diagnostic imaging with radiation exposure.

Conditions

Interventions

PROCEDURE

blood draw

blood draw

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Barbara Parilla, MD · Advocate Health

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-08-31
Completion
2015-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02709174 on ClinicalTrials.gov